Literature DB >> 11973336

Recruitment of Gcn5-containing complexes during c-Myc-dependent gene activation. Structure and function aspects.

Elizabeth M Flinn1, Annika E Wallberg, Stefan Hermann, Patrick A Grant, Jerry L Workman, Anthony P H Wright.   

Abstract

The N-terminal domain of c-Myc plays a key role in cellular transformation and is involved in both activation and repression of target genes as well as in modulated proteolysis of c-Myc via the proteasome. Given this functional complexity, it has been difficult to clarify the structures within the N terminus that contribute to these different processes as well as the mechanisms by which they function. We have used a simplified yeast model system to identify the primary determinants within the N terminus for (i) chromatin remodeling of a promoter, (ii) gene activation from a chromatin template in vivo, and (iii) interaction with highly purified Gcn5 complexes as well as other chromatin-remodeling complexes in vitro. The results identify two regions that contain autonomous chromatin opening and gene activation activity, but both regions are required for efficient interaction with chromatin-remodeling complexes in vitro. The conserved Myc boxes do not play a direct role in gene activation, and Myc box II is not generally required for in vitro interactions with remodeling complexes. The yeast SAGA complex, which is orthologous to the human GCN5-TRRAP complex that interacts with Myc in human cells, plays a role in Myc-mediated chromatin opening at the promoter but may also be involved in later steps of gene activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973336     DOI: 10.1074/jbc.M201704200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Epigenetic reprogramming of Myc target genes.

Authors:  Stefano Amente; Luigi Lania; Barbara Majello
Journal:  Am J Cancer Res       Date:  2011-02-06       Impact factor: 6.166

2.  Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage.

Authors:  Armin M Gamper; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

3.  Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis.

Authors:  Aimee T Farria; Joshua B Plummer; Andrew P Salinger; Jianjun Shen; Kevin Lin; Yue Lu; Kevin M McBride; Evangelia Koutelou; Sharon Y R Dent
Journal:  Cancer Res       Date:  2020-11-09       Impact factor: 12.701

Review 4.  Functions of SAGA in development and disease.

Authors:  Li Wang; Sharon Y R Dent
Journal:  Epigenomics       Date:  2014-06       Impact factor: 4.778

5.  c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation.

Authors:  Xiaohui Liu; Jerusalem Tesfai; Yvonne A Evrard; Sharon Y R Dent; Ernest Martinez
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

6.  Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer.

Authors:  Lisa Maria Mustachio; Jason Roszik; Aimee T Farria; Karla Guerra; Sharon Yr Dent
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

7.  MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits.

Authors:  Na Zhang; Wataru Ichikawa; Francesco Faiola; Szu-Ying Lo; Xiaohui Liu; Ernest Martinez
Journal:  Biochim Biophys Acta       Date:  2014-04-03

Review 8.  The language of chromatin modification in human cancers.

Authors:  Shuai Zhao; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2021-05-17       Impact factor: 60.716

9.  Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia.

Authors:  Eunah Kim; Marek Napierala; Sharon Y R Dent
Journal:  Nucleic Acids Res       Date:  2011-07-10       Impact factor: 16.971

Review 10.  KATs in cancer: functions and therapies.

Authors:  A Farria; W Li; S Y R Dent
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.